Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,106 public trials 2,040 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

NCT02005471

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • University of California San Diego Medical Center La Jolla, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center; Clinical Trials Office New York, United States
  • Perlmutter Cancer Center NYU Langone Health New York, United States
View all 111 locations
View Trial Details
Completed

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

NCT02780804

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasm, +30 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 21 locations
View Trial Details
Completed

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

NCT02304458

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +53 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 25 locations
View Trial Details
Completed

A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL)

NCT04660799

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Peking University Third Hospital Beijing, China
  • The First Hospital of Jilin University Changchun, China
  • Fujian Provincial Cancer Hospital Fuzhou, China
  • Harbin Medical University Cancer Hospital Harbin, China
View Trial Details
Completed

Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis

NCT03120949

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +16 more
Locations
  • AZ Arthritis & Rheum' Research Mesa, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates, P.C. Phoenix, Arizona, United States
  • Arizona Arthritis & Rheumatology Research, PLLC Sun City, Arizona, United States
  • CHI St. Vincent Hot Springs Hot Springs, Arkansas, United States
View all 239 locations
View Trial Details
Completed

First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas

NCT03188965

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 29 locations
View Trial Details
Completed

A Phase 1a Study Evaluating the Safety, Tolerability, and Efficacy of IBI322 in Subjects With Advanced Cancers

NCT04338659

Conditions
Advanced Malignant Tumors Lymphomas, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • The Angeles Clinic And Research Institute Los Angeles, California, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • University Of Mississippi Medical Center Jackson, Mississippi, United States
  • The University of Texas MD Anderson Cancer Center - Investigational Cancer Therapies Houston, Texas, United States
View Trial Details

Related conditions